Brentuximab vedotin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Brentuximab vedotin and local guidelines before prescribing.

Antibody-drug conjugate

Mechanism

CD30 antibody-drug conjugate.

Uses

Hodgkin lymphoma, anaplastic large-cell lymphoma.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Peripheral neuropathy, neutropenia, infusion reactions, PML.

Interactions

Bleomycin contraindicated.

Contraindications and cautions

Concurrent bleomycin

Monitoring

FBC, neuropathy

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Avoid in severe renal or hepatic impairment

Overdose and reversal

Supportive

Special advice

Neuropathy reduces dose.

More from the textbook: uses, cautions and other points
Where it is discussed in the book